GoTelecare Trusts The Viability of Telemedicine to Counter The Coronavirus Menace

Saturday, March 14, 2020 Tropical Disease News
Email Print This Page Comment bookmark
Font : A-A+

Gotelecare firmly believes in the idea of using telemedicine as a potential clinical medium offering flexibility in treating COVID-19

NEW YORK, March 13, 2020 /PRNewswire-PRWeb/ -- With an expected swell in virtual visits, the Senate approved a sweeping spending package in response to the Coronavirus outbreak. The final tally for the Senate vote was 96-1 with appropriations of $8.3 billion in all with $500 million in mandatory to be spent on telehealth program.

The bill gives the Health and Home Services Secretary to suspend rules that restrict access to Medicare patients over the age of 65 years to remote care or telehealth. For doctors to be reimbursed earlier through Medicare through telehealth visits, the patients have to be in certain rural areas / have to be in a facility / they cannot use the service from home. With older adults susceptible to COVID-19, the risks are high with a hospital visit for Medicare patients.

Insurance companies like Anthem are ramping up its telemedicine tool called LiveHealth Online, with a more significant number of physicians and health professionals lined up to consult with patients concerned about Coronavirus.

Companies like Teladoc offering telemedicine services have seen a stock surge in the last week. Telemedicine visits are indeed a great way to minimize exposure, evaluate, and treat from the comfort of one's home.

Telemedicine for long has been an ideal means to expedite care during flu outbreaks. The novel Coronavirus is similar to influenza in how it is transmitted (airborne), how symptoms manifest, and the fear it stirs. If it expands to a wide community spread, Coronavirus like illness will likely be diagnosed on a clinical basis without testing. Those with milder symptoms will be more likely treated at home to limit the spread of the disease as well as not overwhelm the healthcare facilities.

GoTelecare encourages the strides ahead for a mainstream presence of Telemedicine. They firmly believe that Telemedicine expands possibilities to handle the Coronavirus outbreak with reduced wait times, extending easy access to healthcare services over in-person interactions, and improved patient engagement. The company has made a presence over the last decade by working with both the payer and provider side of the healthcare business.

A member of their leadership team and someone who drives their growth initiatives observed, "GoTelecare delivers scalable solutions in Telemedicine and remote patient monitoring devices that helps in streamlining care management. We believe that to deal with Corona Virus , telemedicine finally extends a strong foundation to help physicians interact with patients helping them stay at the comfort of home. "

The company also offers host of solutions in RCM to leading healthcare providers across the country. With Telemedicine, they intend to assist the US Government initiatives to counter the deadly menace of Coronavirus. Physicians today are welcoming the disruptive approach to healthcare, benefits with costs, and extending access to a broader patient base. Believing that Telemedicine is clearly the future, GoTelecare intends to set a benchmark for a value-based model of care.

For Media Inquiries, Contact - Ronnie Hastings Director of Business Development GoTelecare Contact Number: +1-917-565-8683 Email Id: Ronnie.Hastings(at)gotelecare.com

 

SOURCE GoTelecare Telemedicine



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store